With the mounting demand for greater efficiency in the wound caring system, prior to user and clinicians acceptance, extensive clinical and economic evidence is necessary. Advanced wound care products with a higher cost efficiency, is ready to take over traditional wound care products as it ensures rapid healing and scar management, bringing down the nursing time.

STD06, the active component purified from an herb, is under development for various skin disorders and wound healing. STD06 is an active ingredient of a traditional Chinese herbal topical medicine that has been widely used for various skin diseases but heretofore not acceptable as a modern pharmaceutical product. STD06, a patented compound, has been successfully purified and through reformulation process to meet current cosmetic and pharmaceutical standards. In-vitro biological assays showed significant inhibitory activity of STD06 against dermal micro-organisms and inflammatory factors. STD06 is a burgundy-colored crystalline powder that also has the ability to maintain long-term stability as an ointment. Animal pharmacology studies on wound healing and various types of dermatitis are now being evaluated.